How to advocate for the best hATTR-PN care
When my late husband, Aubrey, was diagnosed with hereditary transthyretin amyloidosis with polyneuropathy (hATTR-PN) in 2013, everything changed. Suddenly, our routines were filled with appointments, uncertainty, and the painful realization that the healthcare system was not fully equipped for the journey ahead. For months, we grappled with confusion, fear, and the overwhelming challenge of learning about a condition that neither of us had heard of before.
Very few in our home of New Zealand had heard of the disease, let alone knew how to manage it. Like many families, we learned quickly: Quality healthcare is not something we simply receive. It is something we help shape.
At first, I thought specialists would have all the answers. I believed our role was just to follow instructions. Instead, I discovered that navigating rare disease requires patients and families to be informed and engaged in care. That realization became the foundation of my advocacy work. In this article, I’ll share with you much of what I’ve learned about being a strong advocate.
Advocating for hATTR-PN care begins with knowledge
You cannot assume every healthcare professional understands hATTR-PN. The condition is rare and complex.
Its symptoms — numbness, pain, weakness, dizziness, digestive issues, weight loss, and heart problems — often mimic other, more common conditions. As a result, many patients are misdiagnosed for years, sometimes receiving ineffective treatments while the disease progresses and nerve damage becomes irreversible.
This is why advocating for hATTR-PN care begins with education. You don’t need a medical degree. But you do need enough understanding to participate meaningfully in care conversations.
Focus on understanding:
- how hATTR-PN affects nerves, the heart, digestion, movement, and daily life
- early signs of progression
- available treatments and monitoring approaches
- the role of genetic testing and family screening
- why multidisciplinary care improves outcomes
Knowledge empowers patients to move from passive recipients to active participants in their healthcare. Patients go from receiving information to contributing to decisions.
hATTR amyloidosis patient advocacy is a practical skill
Many people hear the term “rare disease self-advocacy” and think it means pushing back against clinicians.
My experience has taught me the opposite; the strongest advocacy is collaborative.
It means:
- asking questions when something is unclear
- tracking symptoms and changes
- keeping organized medical records
- following up on referrals and investigations
- seeking second opinions when needed
- communicating concerns respectfully
Healthcare professionals bring medical expertise, while patients bring continuity, lived experience, and context. Both forms of expertise matter.
Crucial questions to ask your doctor
Preparation changed the quality of our conversations with specialists. Before appointments, Aubrey and I listed symptoms, concerns, and questions.
These questions will help you prepare:
- How is disease progression monitored and how is treatment success measured?
- What symptoms should trigger an earlier review?
- How often should neurological and cardiac assessments occur?
- What treatment options are currently available? What research supports your recommendation?
- Are there emerging therapies or clinical studies relevant to me?
- Should family members pursue genetic counseling?
- Who is coordinating communication across specialties?
Appointments are more productive when patients are prepared. And the discussions are better retained when you ask your hATTR-PN specialist questions about anything they said that sounded confusing, clarify next steps before leaving, keep a record of the appointment summary, and take someone else to the appointment so you can debrief together.
Keep a detailed symptom log to track small changes
One practical habit that can strengthen care decisions is learning how to track symptom changes over time.
With hATTR-PN, progression can sometimes happen gradually, making small changes difficult to notice in day-to-day life. Rather than relying on memory, consider keeping a simple symptom log that focuses on measurable patterns.
Try documenting:
- frequency of dizziness or episodes of feeling faint
- areas of numbness and whether it is spreading (for example, from toes to the ball of the foot)
- changes in balance, walking distance, or fatigue
- digestive changes such as appetite, bowel habits, nausea, or unintentional weight loss
- changes in pain intensity or timing
- sleep quality and daily function
Quantifying small changes helps capture progressive nerve or autonomic shifts more clearly.
It can also be helpful to record symptoms alongside treatment timing, monitoring dates, or medication changes. Looking at symptom patterns in direct relation to treatment schedules may help specialists identify whether a care plan is maintaining stable effectiveness or whether adjustments and further investigation are needed.
The goal is not to create perfect records. It is to provide a clearer picture of what daily life with hATTR-PN actually looks like between appointments.
Build your expert team of hATTR-PN specialists
Seek multidisciplinary support, since hATTR amyloidosis rarely fits one specialty.
When seeking care, remember that providers will provide the same level of care. Research specialists and treatment centers using reputable medical sources, patient organizations, and healthcare directories. Check out reviews online from multiple sources as well.
If a provider looks good to you, contact their clinic to verify whether clinicians have direct experience managing hATTR-PN or hereditary ATTR amyloidosis rather than treating only general neuropathy conditions. Also ask how frequently they assess disease progression and whether they follow established amyloidosis care pathways.
You can also connect with patient organizations and support communities to learn from others’ experiences and discover practical resources. They may have input on which care teams have provided sufficient care.
If your current care feels insufficient, advocate for the care you need by requesting referrals to providers or centers that may better fit your situation and asking about multidisciplinary care teams.
Connect with the community and find resources
One of the most encouraging changes in the hATTR-PN community over the past few years is the growth of patient advocacy and connection. Establishing the New Zealand Amyloidosis Patients Association reinforced the power of connection for me.
Shared, communal patient advocacy helps:
- increase awareness and share practical experience
- improve diagnostic pathways
- expand treatment access
- connect isolated families
- advance research participation
Stories matter. Each article, conversation, and patient voice creates visibility for the next family.
One of the most practical ways to make the journey easier is to connect with local and condition-specific support networks early. These can often be found through patient organizations, hospital social work teams, specialist clinics, rare disease organizations, online patient communities, and national advocacy groups.
These networks may help families access support that is not always discussed during appointments, including:
- help navigating insurance and healthcare systems
- financial support for treatment and travel expenses
- social workers and patient navigators who coordinate care
- experienced patients and caregivers who can share practical advice
- support groups, webinars, and reliable educational resources
In New Zealand and internationally, some of the most valuable support often comes from people who have already walked the path you are on.
Partnership creates better care
As a caregiver, I learned advocacy can mean listening, not just speaking. Some days, Aubrey had the energy to lead conversations. On other days, he needed me to carry them.
Advocacy means adapting while ensuring concerns are heard. Caregivers must care for themselves, too. Burnout is real. Support is not a luxury; it’s part of sustainable care.
If there’s one message I have for hATTR-PN families, it’s “Don’t underestimate what you know.” Patients should never carry care alone. But they should never underestimate their role in shaping it. The future is not patients waiting for answers, but patients, caregivers, and clinicians working together. In rare disease care, partnership is essential. Together, we shape care that is informed, coordinated, and responsive.
Amyloidosis News Today is strictly a news and information website about the disease. It does not provide medical advice, diagnosis, or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.
